Targeting STAT3 has been shown to induce immunostimulatory effects in different cancer types including AML (24, 25, 50, 51), but the role of STAT3 in AML cell susceptibility to NK cells has not been thoroughly studied. Here, STAT3 is linked to acute myeloid leukemia.